| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $21,702,051 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | K01DA061078 | Reducing opioid misuse among urban Indigenous young adults in Montana using a culturally centered intervention | 000 | 1 | NIH | 7/12/2024 | $176,326 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R25ES022866 | CEHS Summer Undergraduate Research Program: University of Montana | 000 | 9 | NIH | 11/29/2023 | $103,070 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | P1353130 | Rural Residency Planning and Development Program | 01 | 1 | HRSA | 6/26/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | P1353130 | Rural Residency Planning and Development Program | 00 | 1 | HRSA | 6/11/2024 | $750,000 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | U01GM152530 | Rocky Mountain REACH (RMT-REACH) | 001 | 2 | NIH | 8/26/2024 | $6,000 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | U01GM152530 | Rocky Mountain REACH (RMT-REACH) | 001 | 2 | NIH | 8/26/2024 | $152,000 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | U01GM152530 | Rocky Mountain REACH (RMT-REACH) | 001 | 2 | NIH | 8/26/2024 | $192,000 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | U01GM152530 | Rocky Mountain REACH (RMT-REACH) | 001 | 2 | NIH | 8/26/2024 | $101,804 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | U01GM152530 | Rocky Mountain REACH (RMT-REACH) | 001 | 2 | NIH | 8/26/2024 | $48,000 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | U01GM152530 | Rocky Mountain REACH (RMT-REACH) | 001 | 2 | NIH | 8/26/2024 | $480,000 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | S10OD036366 | Acquisition of a Beckman-Coulter Optima AUC Analytical Ultracentrifuge for the University of Montana | 000 | 1 | NIH | 3/14/2024 | $586,559 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R25GM150158 | Improving middle grade STEM interest and increased learning using GN and DOC | 000 | 2 | NIH | 9/4/2024 | $261,559 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | 90RTCP0007 | RTC:Rural - Rural Solutions to Strengthen Disability Community Capacity | 00 | 2 | ACL | 7/22/2024 | $875,000 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | TP1AH000277 | Promotion of Wellness, Education & Resilience Among Native Youth (Native Youth POWER) | 00 | 2 | DHHS/OS | 6/21/2024 | $1,329,154 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | D3449233 | Centers of Excellence | 00 | 2 | HRSA | 5/31/2024 | $628,748 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | F31AI181539 | Sphingomyelin Metabolism Impacts on Crystalline Silica-Induced Outcomes | 001 | 1 | NIH | 8/7/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | F31AI181539 | Sphingomyelin Metabolism Impacts on Crystalline Silica-Induced Outcomes | 000 | 1 | NIH | 8/7/2024 | $38,800 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | 90DDUC0116 | Montana UCEDD: Rural Institute for Inclusive Communities | 00 | 3 | ACL | 6/26/2024 | $620,675 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R00AG073457 | Lifecourse Community Contexts and Health Behaviors as Drivers of Disparities in Risk of Alzheimer's Disease and Related Dementias | 000 | 4 | NIH | 7/5/2024 | $232,271 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R01ES033533 | Role of particle surface functionalization in inflammation | 001 | 3 | NIH | 3/29/2024 | $54,039 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R01ES033533 | Role of particle surface functionalization in inflammation | 000 | 3 | NIH | 3/28/2024 | $501,607 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R01GM148610 | Equipment Supplement to R01GM148610 for an Eppendorf Innova 44R Incubator Shaker | 001 | 3 | NIH | 9/2/2024 | $26,337 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R01GM148610 | Equipment Supplement to R01GM148610 for an Eppendorf Innova 44R Incubator Shaker | 000 | 3 | NIH | 8/7/2024 | $293,077 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R01DK129646 | Structural definition of biased agonism in the nuclear receptor PPAR gamma. | 000 | 3 | NIH | 8/1/2024 | $336,218 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R21DC020251 | Making INformed Decisions in Gaze and Postural Stability (MINDGAPS): a Novel System for Improving Personalized Care and Patient Adherence in Vestibular Rehabilitation | 000 | 3 | NIH | 3/29/2024 | $186,690 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | K00CA253761 | Leveraging Implementation Science to Promote Behavior Change and Reduce Cancer Health Disparities among American Indian and Alaska Native Older Adults | 001 | 6 | NIH | 7/17/2024 | $8,237 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | K00CA253761 | Leveraging Implementation Science to Promote Behavior Change and Reduce Cancer Health Disparities among American Indian and Alaska Native Older Adults | 000 | 6 | NIH | 4/29/2024 | $106,626 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | P20GM130418 | Center for Population Health Research | 002 | 5 | NIH | 6/5/2024 | $250,000 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | P20GM130418 | Center for Population Health Research | 001 | 5 | NIH | 5/3/2024 | $215,940 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | P20GM130418 | Center for Population Health Research | 000 | 5 | NIH | 2/22/2024 | $1,943,463 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | H79SM085125 | National Native Children's Trauma Center | 000 | 2 | SAMHSA | 6/18/2024 | $1,200,000 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R01AI150950 | Rational design of a safe recombinant Candid#1 vaccine | 000 | 4 | NIH | 4/17/2024 | $363,907 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R01NS116055 | Physiology and pharmacology of GluN3-containing NMDA receptors | 001 | 4 | NIH | 4/11/2024 | $25,620 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R01NS116055 | Physiology and pharmacology of GluN3-containing NMDA receptors | 000 | 4 | NIH | 12/8/2023 | $329,400 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | P30GM140963 | Biomolecular Structure and Dynamics: Equipment Supplement for PEAQ-ITC | 002 | 4 | NIH | 9/12/2024 | $205,615 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | P30GM140963 | Biomolecular Structure and Dynamics: Equipment Supplement for PEAQ-ITC | 001 | 4 | NIH | 8/5/2024 | $1,108,200 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R01AI165768 | Population-level assessment of early childhood vaccination timeliness, parental vaccine hesitancy, and immunization schedule adherence in the United States, including rural-urban disparities | 000 | 4 | NIH | 8/7/2024 | $374,192 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | NU58DP007236 | Montana Perinatal Quality Collaborative | 00 | 3 | CDC | 8/20/2024 | $275,000 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | NU58DP007236 | Montana Perinatal Quality Collaborative | 00 | 3 | CDC | 8/20/2024 | $50,000 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R01AI173045 | Phage-mediated horizontal gene transfer in Borrelia burgdorferi | 000 | 1 | NIH | 7/25/2024 | $671,434 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R4353077 | Autism Secondary Data Analysis Program | 02 | 1 | HRSA | 8/9/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R4353077 | Autism Secondary Data Analysis Program | 01 | 1 | HRSA | 7/23/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R4353077 | Autism Secondary Data Analysis Program | 00 | 1 | HRSA | 5/21/2024 | $119,988 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R35GM124701 | The evolutionary genetics and genomics of Wolbachia effects on host physiology | 000 | 8 | NIH | 7/1/2024 | $370,000 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | R35GM124701 | The evolutionary genetics and genomics of Wolbachia effects on host physiology | 001 | 8 | NIH | 8/16/2024 | $128,723 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | UM245792 | Enhancing Systems of Care for Children with Medical Complexity | 00 | 3 | HRSA | 6/6/2024 | $399,862 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | D5837583 | Residency Training in Primary Care | 00 | 5 | HRSA | 5/9/2024 | $491,773 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | 2401MTATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 3 | 1 | ACL | 5/20/2024 | $259,842 |
| | 2024 | 2024 | UNIVERSITY OF MONTANA | 32 CAMPUS DR | MISSOULA | MT | 59812-0003 | MISSOULA | USA | 2401MTATSG | FY2024 (ATSG) AT Act State Grants for Assistive Technology | 2 | 1 | ACL | 3/15/2024 | $66,437 |
|
